Incyte and Genesis Therapeutics are partnering to use artificial intelligence (AI) to research, discover, and develop small molecule treatments. The collaboration could generate up to $620 million for Genesis. The companies will use Genesis’s AI platform, GEMS, for their research. Incyte has exclusive rights for potential clinical development and commercialization of the products developed through the collaboration. The companies have not disclosed the targets they plan to develop.
'Cyber incident' impacting DuPage County Sheriff's Office, DuPage County Courthouse: officials – ABC7 Chicago
A cyber incident has affected the DuPage County Sheriff’s Office and the DuPage County Courthouse, according to officials. The incident is currently under investigation, impacting
